NZ249379A - A cosmetic treatment of inflammatory dermatoses by administering to the affected skin a composition comprising a corticosteroid and a retinoid - Google Patents

A cosmetic treatment of inflammatory dermatoses by administering to the affected skin a composition comprising a corticosteroid and a retinoid

Info

Publication number
NZ249379A
NZ249379A NZ249379A NZ24937993A NZ249379A NZ 249379 A NZ249379 A NZ 249379A NZ 249379 A NZ249379 A NZ 249379A NZ 24937993 A NZ24937993 A NZ 24937993A NZ 249379 A NZ249379 A NZ 249379A
Authority
NZ
New Zealand
Prior art keywords
acid
corticosteroid
tetramethyl
tetrahydro
retinoid
Prior art date
Application number
NZ249379A
Other languages
English (en)
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Priority to NZ286443A priority Critical patent/NZ286443A/en
Publication of NZ249379A publication Critical patent/NZ249379A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ249379A 1992-02-07 1993-01-29 A cosmetic treatment of inflammatory dermatoses by administering to the affected skin a composition comprising a corticosteroid and a retinoid NZ249379A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ286443A NZ286443A (en) 1992-02-07 1993-01-29 Treatment of inflammatory dermatoses other than psoriasis using a retinoid and a corticosteroid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83282892A 1992-02-07 1992-02-07
PCT/US1993/001043 WO1993015740A1 (en) 1992-02-07 1993-01-29 Methods of treating inflammatory dermatoses

Publications (1)

Publication Number Publication Date
NZ249379A true NZ249379A (en) 1998-07-28

Family

ID=25262717

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ249379A NZ249379A (en) 1992-02-07 1993-01-29 A cosmetic treatment of inflammatory dermatoses by administering to the affected skin a composition comprising a corticosteroid and a retinoid

Country Status (12)

Country Link
US (1) US5998395A (OSRAM)
EP (1) EP0625045A4 (OSRAM)
JP (1) JP2927961B2 (OSRAM)
KR (1) KR100282575B1 (OSRAM)
AU (1) AU667519B2 (OSRAM)
CA (1) CA2129114A1 (OSRAM)
CZ (1) CZ188394A3 (OSRAM)
FI (1) FI943625L (OSRAM)
NO (1) NO942913L (OSRAM)
NZ (1) NZ249379A (OSRAM)
WO (1) WO1993015740A1 (OSRAM)
ZA (1) ZA93811B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006434A1 (en) * 1992-09-11 1994-03-31 Sandra Brown Method and composition for the treatment of hair loss
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
DE69623612T2 (de) * 1995-05-05 2003-05-15 Mark S. Braiman Behandlung der psoriasis mit 11-cis-retinsäure
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
AU8588798A (en) 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP1025857A4 (en) * 1997-10-22 2003-11-12 Eisai Co Ltd RETINOIC ACID AGONISTS, PREVENTIVE AND THERAPEUTIC AGENTS FOR NEPHRITES
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
EP1281398B1 (en) * 2000-05-09 2008-07-30 Kaneka Corporation Dermal compositions containing coenzyme q as the active ingredient
US6713515B2 (en) 2000-09-13 2004-03-30 Bristol Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
WO2002071025A2 (en) * 2001-03-02 2002-09-12 Spectra Systems Corporation Combinatorial chemistry and compound identification system
ES2188426B1 (es) * 2001-12-12 2004-11-16 Rosalia Pidal Fernandez Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
US20030199488A1 (en) * 2002-04-23 2003-10-23 Trotta Gina M. Treatment of hyperproliferative disorders/inflammatory dermatoses
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
EP1567113A4 (en) * 2002-10-24 2006-11-08 G & R Pharmaceuticals Llc ANTIFUNGAL PREPARATIONS
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
CN1905870A (zh) * 2003-11-21 2007-01-31 康宾纳特克斯公司 用于治疗炎性病症的方法和试剂
CA2556503A1 (en) * 2004-02-19 2005-09-01 Occell Inc. Topical formulations for the treatment of skin conditions
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
JP2008514189A (ja) 2004-09-28 2008-05-08 ケマファー インコーポレイティッド 体重増加および飼料効率を促進するための組成物および方法
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
KR101762753B1 (ko) 2007-10-26 2017-08-04 아비바젠 인코포레이티드. 면역반응을 증강시키기 위한 조성물 및 그 방법
ES2327201B1 (es) 2008-04-23 2010-07-23 Ignacio Umbert Millet Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico.
NZ596623A (en) 2009-04-30 2014-04-30 Avivagen Inc Methods and compositions for improving the health of animals
WO2011050102A1 (en) 2009-10-20 2011-04-28 Discovery Partners, LLC Dermatologic and cosmetic compositions
ES2378028B1 (es) 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
US10980725B2 (en) 2017-09-28 2021-04-20 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin
RU2712281C1 (ru) * 2018-11-23 2020-01-28 Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
ZA77678B (en) * 1977-02-07 1978-09-27 S Fourie Pharmaceutical composition and use thereof
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy

Also Published As

Publication number Publication date
EP0625045A1 (en) 1994-11-23
EP0625045A4 (en) 1995-01-18
FI943625A7 (fi) 1994-08-04
WO1993015740A1 (en) 1993-08-19
KR100282575B1 (ko) 2001-02-15
FI943625A0 (fi) 1994-08-04
CA2129114A1 (en) 1993-08-19
US5998395A (en) 1999-12-07
AU3585493A (en) 1993-09-03
JP2927961B2 (ja) 1999-07-28
KR950700069A (ko) 1995-01-16
JPH07505617A (ja) 1995-06-22
ZA93811B (en) 1993-09-10
CZ188394A3 (en) 1996-02-14
NO942913L (no) 1994-10-05
NO942913D0 (OSRAM) 1994-08-05
FI943625L (fi) 1994-08-04
AU667519B2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
US5998395A (en) Methods of treating inflammatory dermatosis
US4889847A (en) Prevention of glucocorticoid-induced skin atrophy
Thielitz et al. Topical retinoids in acne vulgaris: update on efficacy and safety
US4294852A (en) Skin treating compositions
US7939516B2 (en) Topical skin care composition
AU2010302940B2 (en) Cosmetic foam
US5019569A (en) Reversal of glucocorticoid-induced skin atrophy
US20070009607A1 (en) Antibacterial/anti-infalmmatory composition and method
Hsu et al. Overview of the treatment of acne vulgaris with topical retinoids
Federman et al. Acne vulgaris: pathogenesis and therapeutic approach
JP3839502B2 (ja) 湿疹・皮膚炎群治療剤
EP3773641B1 (en) Topical pharmaceutical compositions for treating skin conditions
NZ286443A (en) Treatment of inflammatory dermatoses other than psoriasis using a retinoid and a corticosteroid
EP0415458A2 (en) Use of retinoids for preventing and reducing the size of striae distensae lesions
Rajka Emollient therapy in atopic dermatitis
Matt et al. Newer retinoids for psoriasis—Early clinical studies
HK40037195A (en) Topical pharmaceutical compositions for treating skin conditions
HK40037195B (en) Topical pharmaceutical compositions for treating skin conditions
CONS Retinol, Retinyl Esters, and Retinoic Acid
Duffin et al. Topical Agents in the Treatment of Moderate-to-Severe Psoriasis

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired